FDA Fast Tracks tirzepatide for treatment of obesity and weight-related comorbidities Dr. Kamal Kant Kohli8 Oct 2022 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) has Fast Tracked tirzepatide for the treatment of weight-related comorbidities, patients with obesity, or...
Aflibercept with higher dose given at longer interval Promising in neovascular eye disease Dr. Kamal Kant Kohli4 Oct 2022 8:00 PM ISTAflibercept 8 mg is investigational, and its safety and efficacy have not been evaluated by any regulatory authority.According to two randomized...
First once weekly patch available for Alzheimer's dementia Dr. Kamal Kant Kohli4 Oct 2022 11:00 AM ISTAdlarity, a once-weekly patch has been launched and is now available for adults with mild, moderate, or severe dementia of the Alzheimer type.Adlarity...
FDA approves Relyvrio as new treatment option for ALS Dr. Kamal Kant Kohli3 Oct 2022 11:30 AM ISTThe Food and Drug Administration (FDA) has granted approval to a new treatment option in form of Relyvrio (sodium phenylbutyrate and taurursodiol) for...
FDA approves dupilumab as first and only treatment Indicated for Prurigo Nodularis Dr. Kamal Kant Kohli2 Oct 2022 7:30 PM ISTPrurigo nodularis is a chronic, debilitating skin disease with underlying type 2 inflammation and its impact on quality of life is one of the highest...
FDA approves Chloroprocaine Hydrochloride gel for ocular surface anaesthesia Dr. Kamal Kant Kohli30 Sept 2022 9:15 AM ISTThe US Food and Drug Administration (FDA) has approved IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia by...
FDA approves Omidenepag isopropyl eye drops for reduction of elevated IOP Dr. Kamal Kant Kohli27 Sept 2022 7:30 PM ISTUSA: Glaucoma causes damage to the optic nerve resulting in visual field loss, and remains a leading cause of irreversible blindness worldwide. Since...
Gadopiclenol gets FDA approval as new contrast agent for MRI Dr. Kamal Kant Kohli25 Sept 2022 7:30 PM ISTUSA: A new magnetic resonance imaging (MRI) contrast agent, Gadopiclenol, has received US Food and Drug Administration's (FDA's) approval....
FDA approves sodium thiosulfate for for cisplatin-related ototoxicity in children Dr. Kamal Kant Kohli22 Sept 2022 8:30 PM ISTAs of now there have been no approved treatments for preventing cisplatin-induced hearing loss. The US Food And Drug Administration has approved...
FDA Approves APONVIE for Prevention of Postoperative Nausea and Vomitting Dr. Kamal Kant Kohli21 Sept 2022 8:30 PM ISTThe US Food and Drug Administration (FDA) has approved aprepitant as first and only injectable emulsion for preventing nausea and vomiting after...
Dupilumab significantly improves skin lesions and itching among treated patients with prurigo nodularis Dr. Kamal Kant Kohli21 Sept 2022 8:00 PM ISTDupilumab improves skin lesions and itching among treated patients with prurigo nodularis, reveals Initrial data presented at the European Academy of...
FDA approves Rolvedon for chemotherapy induced febrile neutropenia Dr. Kamal Kant Kohli19 Sept 2022 8:00 PM ISTThe Food and Drug Administration (FDA) has approved Rolvedon (eflapegrastim-xnst) to decrease febrile neutropenia among adults with nonmyeloid...
